604 related articles for article (PubMed ID: 29872293)
1. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
[TBL] [Abstract][Full Text] [Related]
2. Folate receptor-targeted ultrasonic PFOB nanoparticles: Synthesis, characterization and application in tumor-targeted imaging.
Li K; Liu Y; Zhang S; Xu Y; Jiang J; Yin F; Hu Y; Han B; Ge S; Zhang L; Wang Y
Int J Mol Med; 2017 Jun; 39(6):1505-1515. PubMed ID: 28487935
[TBL] [Abstract][Full Text] [Related]
3. Activatable near infrared dye conjugated hyaluronic acid based nanoparticles as a targeted theranostic agent for enhanced fluorescence/CT/photoacoustic imaging guided photothermal therapy.
Liang X; Fang L; Li X; Zhang X; Wang F
Biomaterials; 2017 Jul; 132():72-84. PubMed ID: 28411450
[TBL] [Abstract][Full Text] [Related]
4. Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery.
Min HS; Son S; You DG; Lee TW; Lee J; Lee S; Yhee JY; Lee J; Han MH; Park JH; Kim SH; Choi K; Park K; Kim K; Kwon IC
Biomaterials; 2016 Nov; 108():57-70. PubMed ID: 27619240
[TBL] [Abstract][Full Text] [Related]
5. Carboxyl of Poly(D,L-lactide-co-glycolide) Nanoparticles of Perfluorooctyl Bromide for Ultrasonic Imaging of Tumor.
Luo S; Ding J; Wang P; Wang Z; Ma X; Yang C; Liang Q; Rong P; Wang W
Contrast Media Mol Imaging; 2018; 2018():2957459. PubMed ID: 29568245
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
7. Towards a nanoscale mammographic contrast agent: development of a modular pre-clinical dual optical/x-ray agent.
Hill ML; Gorelikov I; Niroui F; Levitin RB; Mainprize JG; Yaffe MJ; Rowlands JA; Matsuura N
Phys Med Biol; 2013 Aug; 58(15):5215-35. PubMed ID: 23851978
[TBL] [Abstract][Full Text] [Related]
8. Coating microbubbles with nanoparticles for medical imaging and drug delivery.
Tay LM; Xu C
Nanomedicine (Lond); 2017 Jan; 12(2):91-94. PubMed ID: 27876447
[No Abstract] [Full Text] [Related]
9. Physical and acoustical properties of perfluorooctylbromide, an ultrasound contrast agent.
André M; Nelson T; Mattrey R
Invest Radiol; 1990 Sep; 25(9):983-7. PubMed ID: 2211056
[TBL] [Abstract][Full Text] [Related]
10. Polymer-Based Materials in Cancer Treatment: From Therapeutic Carrier and Ultrasound Contrast Agent to Theranostic Applications.
Methachan B; Thanapprapasr K
Ultrasound Med Biol; 2017 Jan; 43(1):69-82. PubMed ID: 27751594
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
[TBL] [Abstract][Full Text] [Related]
12. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
13. Perfluorooctyl bromide traces self-assembled with polymeric nanovesicles for blood pool ultrasound imaging.
Li H; Wang P; Wang X; Yin T; Zhou G; Shuai X; Zheng R
Biomater Sci; 2016 Jun; 4(6):979-88. PubMed ID: 27121357
[TBL] [Abstract][Full Text] [Related]
14. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
[TBL] [Abstract][Full Text] [Related]
15. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles.
Hu Z; Yang B; Li T; Li J
Contrast Media Mol Imaging; 2018; 2018():8710862. PubMed ID: 29706844
[TBL] [Abstract][Full Text] [Related]
17. Thin-Shelled PEGylated Perfluorooctyl Bromide Nanocapsules for Tumor-Targeted Ultrasound Contrast Agent.
Achmad A; Yamaguchi A; Hanaoka H; Tsushima Y
Contrast Media Mol Imaging; 2018; 2018():1725323. PubMed ID: 30515065
[TBL] [Abstract][Full Text] [Related]
18. Development and application of ultrasound contrast agents in biomedicine.
Wang Y; Cong H; Wang S; Yu B; Shen Y
J Mater Chem B; 2021 Sep; 9(37):7633-7661. PubMed ID: 34586124
[TBL] [Abstract][Full Text] [Related]
19. Copper Sulfide Perfluorocarbon Nanodroplets as Clinically Relevant Photoacoustic/Ultrasound Imaging Agents.
Santiesteban DY; Dumani DS; Profili D; Emelianov SY
Nano Lett; 2017 Oct; 17(10):5984-5989. PubMed ID: 28926263
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.
Caruthers SD; Cyrus T; Winter PM; Wickline SA; Lanza GM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):311-23. PubMed ID: 20049799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
